{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:54:37Z","timestamp":1778169277596,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1124\/jpet.104.068122","type":"journal-article","created":{"date-parts":[[2004,8,21]],"date-time":"2004-08-21T05:57:29Z","timestamp":1093067849000},"page":"1046-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["An Engineered Cocaine Hydrolase Blunts and Reverses Cardiovascular Responses to Cocaine in Rats"],"prefix":"10.1016","volume":"310","author":[{"given":"Yang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Brimijoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.068122_bib1","doi-asserted-by":"crossref","unstructured":"Altamirano C and Lockridge O (1999) Association of tetramers of human butyrylcholinesterase is mediated by conserved aromatic residues of the carboxy terminus. Chem Biol Interact 119\u2013120: 53-60.","DOI":"10.1016\/S0009-2797(99)00013-7"},{"key":"10.1124\/jpet.104.068122_bib2","doi-asserted-by":"crossref","unstructured":"Beckman KJ, Parker RB, Hariman RJ, Gallastegui JL, Javaid JI, and Bauman JL (1991) Hemodynamic and electrophysiological actions of cocaine: effects of sodium bicarbonate as an antidote in dogs. Circulation 83: 1799-1807.","DOI":"10.1161\/01.CIR.83.5.1799"},{"key":"10.1124\/jpet.104.068122_bib3","doi-asserted-by":"crossref","unstructured":"Benchimol A, Bartall H, and Desser KB (1978) Accelerated ventricular rhythm and cocaine abuse. Ann Int Med 88: 519-520.","DOI":"10.7326\/0003-4819-88-4-519"},{"key":"10.1124\/jpet.104.068122_bib4","doi-asserted-by":"crossref","unstructured":"Benowitz N (1993) Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 72: 3-12.","DOI":"10.1111\/j.1600-0773.1993.tb01331.x"},{"key":"10.1124\/jpet.104.068122_bib5","doi-asserted-by":"crossref","unstructured":"Bresler M, Rosser S, Basran A, and Bruce N (2000) Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl Environ Microbiol 66: 904-908.","DOI":"10.1128\/AEM.66.3.904-908.2000"},{"key":"10.1124\/jpet.104.068122_bib6","doi-asserted-by":"crossref","unstructured":"Brimijoin S, Shen M, and Sun H (2002) Radiometric solvent-partitioning assay for screening cocaine hydrolases and measuring cocaine levels in milligram tissue samples. Anal Biochem 309: 200-205.","DOI":"10.1016\/S0003-2697(02)00238-5"},{"key":"10.1124\/jpet.104.068122_bib7","unstructured":"Brown JH and Taylor P (2001) Muscarinic receptor agonists and antagonists, in Goodman & Gilman\u2019s Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds), McGraw-Hill, New York."},{"key":"10.1124\/jpet.104.068122_bib8","doi-asserted-by":"crossref","unstructured":"Carmona G, Jufer R, Goldberg S, Gorelick D, Greig N, Yu Q, Cone E, and Schindler C (2000) Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans. Drug Metab Dispos 28: 367-371.","DOI":"10.1016\/S0090-9556(24)15375-5"},{"key":"10.1124\/jpet.104.068122_bib9","doi-asserted-by":"crossref","unstructured":"Carmona GN, Schindler CW, Shoaib M, Jufter R, Cone EJ, Goldberg SR, Greig NH, Yu QS, and Gorelick DA (1998) Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase. Exp Clin Psychopharmacol 6: 274-279.","DOI":"10.1037\/\/1064-1297.6.3.274"},{"key":"10.1124\/jpet.104.068122_bib10","doi-asserted-by":"crossref","unstructured":"Carroll FI, Howell LL, and Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42: 2721-2736.","DOI":"10.1021\/jm9706729"},{"key":"10.1124\/jpet.104.068122_bib11","unstructured":"Cascio C, Comite C, and Ghiara M (1982) The use of serum cholinesterase in severe phosphorus poisoning. Minerva Anestesiol 54: 337-338."},{"key":"10.1124\/jpet.104.068122_bib12","unstructured":"Charney DS, Mihic J, and Harris RA (2001) Hypnotics and sedatives, in Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds) ed 10, pp 399-427, McGraw-Hill, New York."},{"key":"10.1124\/jpet.104.068122_bib13","unstructured":"Doctor BP (2003) Butyrylcholinesterase: its use for prophylaxis of organophosphate exposure, in Butyrylcholinesterase: Its Function and Inhibitors (Giacobini E ed.), pp 163-177, Martin Dunitz, London."},{"key":"10.1124\/jpet.104.068122_bib14","doi-asserted-by":"crossref","unstructured":"Ebert TJ (1990) Inhibition of sympathetic neural outflow during thiopental anesthesia in humans. Anesth Analg 71: 319-326.","DOI":"10.1213\/00000539-199010000-00001"},{"key":"10.1124\/jpet.104.068122_bib15","doi-asserted-by":"crossref","unstructured":"Ellman GL, Courtney KD, Andres VJ, and Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.","DOI":"10.1016\/0006-2952(61)90145-9"},{"key":"10.1124\/jpet.104.068122_bib16","doi-asserted-by":"crossref","unstructured":"Gorelick D (1997) Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol Depend 48: 159-165.","DOI":"10.1016\/S0376-8716(97)00119-1"},{"key":"10.1124\/jpet.104.068122_bib17","doi-asserted-by":"crossref","unstructured":"Hoffman R, Morasco R, and Goldfrank L (1996) Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol 34: 259-266.","DOI":"10.3109\/15563659609013786"},{"key":"10.1124\/jpet.104.068122_bib18","doi-asserted-by":"crossref","unstructured":"Inaba T, Stewart D, and Kalow W (1978) Metabolism of cocaine in man. Clin Pharmacol Ther 23: 547-552.","DOI":"10.1002\/cpt1978235547"},{"key":"10.1124\/jpet.104.068122_bib19","doi-asserted-by":"crossref","unstructured":"Jain R, Jain M, Bachenheimer L, Visner M, Hamosh P, Tracy C, and Gillis R (1990) Factors determining whether cocaine will potentiate the cardiac effects of neurally released norepinephrine. J Pharmacol Exp Ther 252: 147-153.","DOI":"10.1016\/S0022-3565(25)13321-1"},{"key":"10.1124\/jpet.104.068122_bib20","doi-asserted-by":"crossref","unstructured":"Krejci E, Thomine S, Boschetti N, Legay C, Sketelj J, and Massoulie J (1997) The mammalian gene of acetylcholinesterase-associated collagen. J Biol Chem 272: 22840-22847.","DOI":"10.1074\/jbc.272.36.22840"},{"key":"10.1124\/jpet.104.068122_bib21","doi-asserted-by":"crossref","unstructured":"Landry DW, Zhao K, Yang GX-Q, Glickman M, and Georgiadis TM (1993) Antibody-catalyzed degradation of cocaine. Science (Wash DC) 259: 1899-1901.","DOI":"10.1126\/science.8456315"},{"key":"10.1124\/jpet.104.068122_bib22","doi-asserted-by":"crossref","unstructured":"Lynch T, Mattes C, Singh A, Bradley R, Brady R, and Dretchen K (1997) Cocaine detoxification by human plasma butyrylcholinesterase. J Appl Pharmacol 145: 363-371.","DOI":"10.1006\/taap.1997.8187"},{"key":"10.1124\/jpet.104.068122_bib23","doi-asserted-by":"crossref","unstructured":"Marzuk P, Tardiff K, Leon A, Hirsch C, Stajic M, Portera L, Hartwell N, and Iqbal M (1995) Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med 332: 1753-1757.","DOI":"10.1056\/NEJM199506293322606"},{"key":"10.1124\/jpet.104.068122_bib24","doi-asserted-by":"crossref","unstructured":"Mattes C, Lynch T, Singh A, Bradley R, Kellaris P, Brady R, and Dretchen K (1997) Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol Appl Pharmacol 145: 372-380.","DOI":"10.1006\/taap.1997.8188"},{"key":"10.1124\/jpet.104.068122_bib25","doi-asserted-by":"crossref","unstructured":"McKinney M (1998) Practical aspects of radioligand binding, in Current Protocols of Pharmacology, pp 1.3.1-1.3.33. John Wiley & Sons, New York.","DOI":"10.1002\/0471141755.ph0103s00"},{"key":"10.1124\/jpet.104.068122_bib26","doi-asserted-by":"crossref","unstructured":"Ostergaard D, Viby-Morgensen J, Hanel HK, and Skovgaard LT (1988) Half-life of plasma cholinesterase. Acta Anesth Scand 32: 266-269.","DOI":"10.1111\/j.1399-6576.1988.tb02727.x"},{"key":"10.1124\/jpet.104.068122_bib27","unstructured":"Pancook JD, Pecht G, Ader M, Mosko M, Lockridge O, and Watkins JD (2003) Application of directed evolution technology to optimize the cocaine hydrolase activity of human butyrylcholinesterase. FASEB J 17: A565."},{"key":"10.1124\/jpet.104.068122_bib28","doi-asserted-by":"crossref","unstructured":"Pascual-Leone A, Dhuna A, Altafulla I, and Anderson DC (1990) Cocaine-induced seizures. Neurology 40: 404-407.","DOI":"10.1212\/WNL.40.3_Part_1.404"},{"key":"10.1124\/jpet.104.068122_bib29","doi-asserted-by":"crossref","unstructured":"Pitts DK, Udom CE, and Marwah J (1987) Cardiovascular effects of cocaine in anesthetized and conscious rats. Life Sci 40: 1099-1111.","DOI":"10.1016\/0024-3205(87)90573-X"},{"key":"10.1124\/jpet.104.068122_bib30","doi-asserted-by":"crossref","unstructured":"Przywara DA and Dambach GE (1989) Direct actions of cocaine on cardiac cellular electrical activity. Circ Res 65: 185-192.","DOI":"10.1161\/01.RES.65.1.185"},{"key":"10.1124\/jpet.104.068122_bib31","doi-asserted-by":"crossref","unstructured":"Rosenberg Y, Luo C, Ashani Y, Doctor BP, Fischer R, Wolfe G, and Saxena A (2002) Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase. Life Sci 72: 125-134.","DOI":"10.1016\/S0024-3205(02)02203-8"},{"key":"10.1124\/jpet.104.068122_bib32","doi-asserted-by":"crossref","unstructured":"Stewart DJ, Inaba T, Tang BK, and Kalow W (1977) Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 20: 1557-1564.","DOI":"10.1016\/0024-3205(77)90448-9"},{"key":"10.1124\/jpet.104.068122_bib33","doi-asserted-by":"crossref","unstructured":"Stovner J and Stadskleiv K (1976) Suxamethonium apnea terminated with commercial serum cholinesterase. Acta Anaesth Scand 20: 211-215.","DOI":"10.1111\/j.1399-6576.1976.tb05031.x"},{"key":"10.1124\/jpet.104.068122_bib34","doi-asserted-by":"crossref","unstructured":"Sun H, El Yazal J, Brimijoin S, and Pang Y-P (2001) Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase: engineering effective butyrylcholinesterase mutants for cocaine detoxification. J Biol Chem 276: 9330-9336.","DOI":"10.1074\/jbc.M006676200"},{"key":"10.1124\/jpet.104.068122_bib35","doi-asserted-by":"crossref","unstructured":"Sun H, Pang Y-P, Lockridge O, and Brimijoin S (2002a) Re-engineering butyrylcholinesterase as a cocaine hydrolase. Mol Pharmacol 621: 220-224.","DOI":"10.1124\/mol.62.2.220"},{"key":"10.1124\/jpet.104.068122_bib36","doi-asserted-by":"crossref","unstructured":"Sun H, Shen ML, Pang Y-P, Lockridge O, and Brimijoin S (2002b) Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. J Pharmacol Exp Ther 302: 710-716.","DOI":"10.1124\/jpet.302.2.710"},{"key":"10.1124\/jpet.104.068122_bib37","doi-asserted-by":"crossref","unstructured":"Trendelenburg U (1966) Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 18: 629-640.","DOI":"10.1016\/S0031-6997(25)07201-1"},{"key":"10.1124\/jpet.104.068122_bib38","doi-asserted-by":"crossref","unstructured":"Winbery S, Blaho K, Logan B, and Geraci S (1998) Multiple cocaine-induced seizures and corresponding cocaine and metabolite concentrations. Am J Emerg Med 16: 529-533.","DOI":"10.1016\/S0735-6757(98)90012-2"},{"key":"10.1124\/jpet.104.068122_bib39","doi-asserted-by":"crossref","unstructured":"Xie W, Altamirano CV, Bartels CF, Speirs RJ, Cashman JR, and Lockridge O (1999) An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient. Mol Pharmacol 55: 83-91.","DOI":"10.1124\/mol.55.1.83"},{"key":"10.1124\/jpet.104.068122_bib40","doi-asserted-by":"crossref","unstructured":"Zhan C, Zheng F, and Landry D (2003) Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. J Am Chem Soc 125: 2462-2474.","DOI":"10.1021\/ja020850+"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524315320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524315320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.068122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:58:43Z","timestamp":1739998723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524315320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0022356524315320"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.068122","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Engineered Cocaine Hydrolase Blunts and Reverses Cardiovascular Responses to Cocaine in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.068122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}